These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 17317031)
1. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium. Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
4. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812 [TBL] [Abstract][Full Text] [Related]
5. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology]. Amălinei C; Căruntu ID; Balan R; Cianga C; Cianga P Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):437-48. PubMed ID: 19295017 [TBL] [Abstract][Full Text] [Related]
6. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303 [TBL] [Abstract][Full Text] [Related]
7. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer. Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060 [TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Niikura H; Sasano H; Kaga K; Sato S; Yajima A Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044 [TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983 [TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of Beclin1 and PTEN in endometrial carcinoma]. Zhao JH; Wan XY; Xie X; Zhou CY; Wu QY Ai Zheng; 2006 Jun; 25(6):753-7. PubMed ID: 16764775 [TBL] [Abstract][Full Text] [Related]
11. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma. Guo T; Li B; Gu C J BUON; 2013; 18(2):465-70. PubMed ID: 23818363 [TBL] [Abstract][Full Text] [Related]
12. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium. Ioffe OB; Papadimitriou JC; Drachenberg CB Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Vaskivuo TE; Stenbäck F; Tapanainen JS Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915 [TBL] [Abstract][Full Text] [Related]
14. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions]. Xiong Y; Xiong YY; Zhou YF Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium. Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680 [TBL] [Abstract][Full Text] [Related]
16. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539 [TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers. Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803 [TBL] [Abstract][Full Text] [Related]
19. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma]. Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203 [TBL] [Abstract][Full Text] [Related]
20. FGFR2 alterations in endometrial carcinoma. Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]